UBS Group AG - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 25 filers reported holding ACASTI PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2021$15,000
+66.7%
26,094
+35.2%
0.00%
Q2 2020$9,000
-57.1%
19,302
-64.8%
0.00%
Q1 2020$21,000
+23.5%
54,889
+684.8%
0.00%
Q4 2019$17,000
+142.9%
6,994
+87.0%
0.00%
Q3 2019$7,000
-53.3%
3,741
-70.7%
0.00%
Q2 2019$15,000
-44.4%
12,761
-52.0%
0.00%
Q1 2019$27,000
+800.0%
26,564
+486.5%
0.00%
Q2 2018$3,000
+200.0%
4,529
+353.8%
0.00%
Q1 2018$1,000
-94.4%
998
-94.7%
0.00%
Q4 2017$18,000
+350.0%
18,737
+462.2%
0.00%
Q4 2016$4,000
+100.0%
3,333
+214.1%
0.00%
Q3 2016$2,000
-60.0%
1,061
-70.6%
0.00%
Q1 2016$5,000
+25.0%
3,606
+111.1%
0.00%
Q4 2015$4,0001,7080.00%
Other shareholders
ACASTI PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 145,202$137,0000.01%
Perceptive Advisors 186,559$176,0000.01%
INTACT INVESTMENT MANAGEMENT INC. 88,990$106,0000.00%
WELLS FARGO & COMPANY/MN 8,630$8,0000.00%
TORONTO DOMINION BANK 7$00.00%
DEUTSCHE BANK AG\ 252,603$238,0000.00%
MORGAN STANLEY 40,000$38,0000.00%
BANK OF MONTREAL /CAN/ 212$00.00%
Citadel Advisors 25,980$24,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 559,835$528,0000.00%
View complete list of ACASTI PHARMA INC shareholders